MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $656,052 | -35.3% | 40,901 | -6.5% | 0.01% | -33.3% |
Q2 2023 | $1,014,055 | -4.7% | 43,747 | -4.5% | 0.01% | -14.3% |
Q1 2023 | $1,064,166 | -29.2% | 45,810 | -55.7% | 0.01% | +40.0% |
Q4 2022 | $1,502,076 | +20.5% | 103,520 | +58.4% | 0.01% | -44.4% |
Q3 2022 | $1,247,000 | +4.2% | 65,345 | -0.8% | 0.02% | +12.5% |
Q2 2022 | $1,197,000 | -32.1% | 65,866 | -5.8% | 0.02% | -15.8% |
Q1 2022 | $1,762,000 | -9.9% | 69,921 | -1.3% | 0.02% | -5.0% |
Q4 2021 | $1,955,000 | – | 70,818 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 6,459,139 | $278,776,000 | 5.53% |
Tieton Capital Management, LLC | 119,290 | $5,149,000 | 4.04% |
RPg Family Wealth Advisory, LLC | 97,202 | $4,195,238,000 | 3.85% |
RK Capital | 384,900 | $16,612,000 | 2.90% |
Contrarius Investment Management Ltd | 652,288 | $28,153,000 | 2.65% |
S&T BANK/PA | 331,885 | $14,324,000 | 2.22% |
Euclidean Technologies Management, LLC | 40,917 | $1,766,000 | 1.90% |
AIMZ Investment Advisors, LLC | 45,635 | $1,970,000 | 1.80% |
Taylor Frigon Capital Management LLC | 34,783 | $1,486,000 | 1.67% |
KILLEN GROUP INC | 366,305 | $15,810,000 | 1.63% |